Clinical trial
Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal…
NCT00390910 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00390910 |
|---|---|
| Title | Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants |
| Official title | Study to Assess the Safety and Immunogenicity of GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine When Co-administered With DTPa-HBV-IPV/Hib (Infanrix-Hexa) Vaccine in Preterm Infants as a 3-dose Primary Immunization Course During the First 6 Months of Life. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Streptococcal |
| Intervention type | Biological |
| Interventions | Pneumococcal conjugate vaccine GSK1024850A, Infanrix hexa |
| Enrollment | 286 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 2, 2007 |
| Completion | May 2, 2008 |
| First posted | Oct 23, 2006 |
| Last update posted | Dec 17, 2018 |
| Countries | Greece, Spain |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: